Score of Hellstrom-Lindberg for Predicting Response to Erythropoietin Plus Granulocyte Colony Stimulating Factor in an Anemic Patient with Myelodysplasia

Purpose: To determine if an anemic patient with myelo-dysplasia will respond to therapy with erythropoietin plus GCSF based on the score of Hellstrom-Lindberg.

Info MyLikes MyPaths

Evaluation

Are you evaluating an anemic patient with myelodysplasia?

Yes

Serum erythropoietin concentration

IU/L

Number of monthly blood tranfusions

• six months ago

units RBCs

• five months ago

units RBCs

• four months ago

units RBCs

• three months ago

units RBCs

• two months ago

units RBCs

• last month

units RBCs

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Average monthly blood transfusion requirements for past 6 months

Total score

Probable response to erythropoietin plus GCSF therapy

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Therapy

Administration
- Prediction Rules of Ludwig for Response to Erythropoietin in a Patient with Cancer and Chronic Anemia

Monitoring

Response To Therapy
- Prediction Rules of Ludwig for Response to Erythropoietin in a Patient with Cancer and Chronic Anemia
Adverse Effects
- Prediction Rules of Ludwig for Response to Erythropoietin in a Patient with Cancer and Chronic Anemia
Drug Levels
- Prediction Rules of Ludwig for Response to Erythropoietin in a Patient with Cancer and Chronic Anemia

Specialty

Hematology Oncology
Clinical Laboratory

Objective

selection
administration
response to therapy

ICD-10

D46 - Myelodysplastic syndromes
D50-D53 - Nutritional anaemias
D55-D59 - Haemolytic anaemias
D60-D64 - Aplastic and other anaemias
D63 - Anaemia in chronic diseases classified elsewhere

Info

Purpose: To determine if an anemic patient with myelo-dysplasia will respond to therapy with erythropoietin plus GCSF based on the score of Hellstrom-Lindberg.

Specialty: Hematology Oncology, Clinical Laboratory

Objective: selection, administration, response to therapy

ICD-10: D46, D50-D53, D55-D59, D60-D64, D63,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path